Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minjiang Chen

Showing results (51-60 of 279) with videos related to

Pageof 28
Sort By:
Frontiers in Pharmacology|July 28, 2022
Corrigendum: Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER StressQianqian Zhang, Weiqian Chen, Xiuling Lv, et al.
Respirology (Carlton, Vic.)|December 15, 2015
Relationship between circulating tumour cell count and prognosis following chemotherapy in patients with advanced non-small-cell lung cancerZixuan Zhang, Yi Xiao, Jing Zhao, et al.
Biomed Research International|July 15, 2016
High Glucose-Induced PC12 Cell Death by Increasing Glutamate Production and Decreasing Methyl Group MetabolismMinjiang Chen, Hong Zheng, Tingting Wei, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 2023
The role of metabolic reprogramming of oxygen-induced macrophages in the dynamic changes of atherosclerotic plaquesLin Shen, Weiyue Chen, Jiayi Ding, et al.
BMC Cancer|December 6, 2025
Clinical outcomes and predictive factors of immunotherapy efficacy in non-small-cell lung cancer brain metastases: a comparative studyYuxi Wei, Rongzhen Li, Xiaoyan Liu, et al.
Therapeutic Advances in Medical Oncology|August 7, 2019
Immunotherapy for hepatocellular carcinoma: recent advances and future perspectivesWeiqi Xu, Ken Liu, Minjiang Chen, et al.
Cancer Management and Research|October 1, 2019
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinibHongge Liang, Di Ma, Yan Xu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|April 25, 2019
[Next Steps after Negative Results Obtained by EBUS-TBNA from Patients Suspected Clinically Lung Cancer with Mediastinal Lymphnode Metastasis]Yongjian Liu, Minjiang Chen, Xuefeng Sun, et al.
Journal of Medical Genetics|August 19, 2018
Global microarray profiling identified <i>hsa_circ_0064428</i> as a potential immune-associated prognosis biomarker for hepatocellular carcinomaQiaoyou Weng, Minjiang Chen, Maoquan Li, et al.
Clinical Lung Cancer|August 1, 2012
Cerebrospinal fluid concentrations of gefitinib in patients with lung adenocarcinomaJing Zhao, Minjiang Chen, Wei Zhong, et al.
Pageof 28

Showing results (51-60 of 279) with videos related to

Sort By:
Pageof 28
Frontiers in Pharmacology|July 28, 2022
Corrigendum: Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER StressQianqian Zhang, Weiqian Chen, Xiuling Lv, et al.
Respirology (Carlton, Vic.)|December 15, 2015
Relationship between circulating tumour cell count and prognosis following chemotherapy in patients with advanced non-small-cell lung cancerZixuan Zhang, Yi Xiao, Jing Zhao, et al.
Biomed Research International|July 15, 2016
High Glucose-Induced PC12 Cell Death by Increasing Glutamate Production and Decreasing Methyl Group MetabolismMinjiang Chen, Hong Zheng, Tingting Wei, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 1, 2023
The role of metabolic reprogramming of oxygen-induced macrophages in the dynamic changes of atherosclerotic plaquesLin Shen, Weiyue Chen, Jiayi Ding, et al.
BMC Cancer|December 6, 2025
Clinical outcomes and predictive factors of immunotherapy efficacy in non-small-cell lung cancer brain metastases: a comparative studyYuxi Wei, Rongzhen Li, Xiaoyan Liu, et al.
Therapeutic Advances in Medical Oncology|August 7, 2019
Immunotherapy for hepatocellular carcinoma: recent advances and future perspectivesWeiqi Xu, Ken Liu, Minjiang Chen, et al.
Cancer Management and Research|October 1, 2019
Elevated levels of pre-treatment lactate dehydrogenase are an unfavorable predictor factor in patients with EML4-ALK rearrangement non-small cell lung cancer treated with crizotinibHongge Liang, Di Ma, Yan Xu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|April 25, 2019
[Next Steps after Negative Results Obtained by EBUS-TBNA from Patients Suspected Clinically Lung Cancer with Mediastinal Lymphnode Metastasis]Yongjian Liu, Minjiang Chen, Xuefeng Sun, et al.
Journal of Medical Genetics|August 19, 2018
Global microarray profiling identified <i>hsa_circ_0064428</i> as a potential immune-associated prognosis biomarker for hepatocellular carcinomaQiaoyou Weng, Minjiang Chen, Maoquan Li, et al.
Clinical Lung Cancer|August 1, 2012
Cerebrospinal fluid concentrations of gefitinib in patients with lung adenocarcinomaJing Zhao, Minjiang Chen, Wei Zhong, et al.
Pageof 28